The content is available as a PDF (828.5 KB).
Supporting information
Additional Supporting Information may be found in the online version of this article.
Supplementary Table I: Expression of CD1c and CD1d in HL and NHL.
Click here for additional data file. (148KB, doc)
†
Conflict of interest: Nothing to report.
References
- 1. Poppema S. Immunobiology and pathophysiology of Hodgkin lymphomas. Hematology Am Soc Hematol Educ Program 2005: 231–238. [DOI] [PubMed] [Google Scholar]
- 2. Diepstra A,van Imhoff G,Karim‐Kos H, et al. HLA class II expression by Hodgkin Reed‐Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma. J Clin Oncol 2007; 25: 3101–3108. [DOI] [PubMed] [Google Scholar]
- 3. Zheng Z,Venkatapathy S,Rao G, et al. Expression profiling of B cell chronic lymphocytic leukemia suggests deficient CD1‐mediated immunity, polarized cytokine response, altered adhesion and increased intracellular protein transport and processing leukemic cells. Leukemia 2002; 16: 2429–2437. [DOI] [PubMed] [Google Scholar]
- 4. Fais F,Morabito F,Stelitano C, et al. CD1d is expressed on B‐chronic lymphocytic leukemia cells and mediates alpha‐galactosylceramide presentation to natural killer T lymphocytes. Int J Cancer 2004; 109: 402–411. [DOI] [PubMed] [Google Scholar]
- 5. Dhodapkar M,Geller M,Chang D, et al. A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma. J Exp Med 2003; 197: 1667–1676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Renukaradhya G,Khan M,Vieira M, et al. Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B‐cell lymphoma. Blood 2008; 111: 5637–5645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Brigl M,Brenner MB. CD1: Antigen presentation and T cell function. Annu Rev Immunol 2004; 22: 817–890. [DOI] [PubMed] [Google Scholar]
- 8. Sieling PA,Ochoa MT,Jullien D, et al. Evidence for human CD4+ T cells in the CD1 restricted repertoire: Derivation of mycobacteria‐reactive T cells from leprosy lesions. J Immunol 2000; 164: 4790–4796. [DOI] [PubMed] [Google Scholar]
- 9. Dellabonna P,Padovan E,Casorati G, et al. An invariant V alpha 24‐J alpha Q/V beta 11 Tcell receptor is expressed in all individuals by clonally expanded CD4‐CD8‐T cells. J Exp Med 1994; 180: 1171–1176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Gumperz J,Miyake S,Yamamura T,Brenner M. Functionally distinct subsets of CD1d‐restricted natural killer T cells revealed by CD1d tetramer staining. J Exp Med 2002; 195: 625–636. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Smith ME,Thomas JA,Bodmer WF. CD1c antigens are present in normal and neoplastic B‐cells. J Pathol 1988; 156: 169–177. [DOI] [PubMed] [Google Scholar]
- 12. Kanzler H,Kuppers R,Hansmann ML,Rajewsky K. Hodgkin and Reed‐Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996; 184: 1495–1505. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13. Kim LH,Eow GI,Peh SC,Poppema S. The role of CD30, CD40 and CD95 in the regulation of proliferation and apoptosis in classical Hodgkin's lymphoma. Pathology 2003; 35: 428–435. [DOI] [PubMed] [Google Scholar]
- 14. Exley M,Garcia J,Wilson SB, et al. CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes. Immunology 2000; 100: 37–47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Niens M,Visser L,Nolte IM, et al. Serum chemokine levels in Hodgkin lymphoma patients: Highly increased levels of CCL17 and CCL22. Br J Haematol 2008; 140: 527–536. [DOI] [PubMed] [Google Scholar]
- 16. Kim C,Johnston B,Butcher E. Trafficking machinery of NKT cells: Shared and differential chemokine receptor expression among Valpha 24+Vbeta 11+ NKT cell subsets with distinct cytokine‐producing capacity. Blood 2002; 100: 11–16. [DOI] [PubMed] [Google Scholar]
- 17. Ma Y,Visser L,Blokzijl T, et al. The CD4+CD26‐T‐cell population in classical Hodgkin's lymphoma displays a distinctive regulatory T‐cell profile. Lab Invest 2008; 88: 482–490. [DOI] [PubMed] [Google Scholar]
- 18. Mader A,Bruderlein S,Wegener S, et al. U‐HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma. Cytogenet Genome Res 2007; 119: 204–210. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Additional Supporting Information may be found in the online version of this article.
Supplementary Table I: Expression of CD1c and CD1d in HL and NHL.
Click here for additional data file. (148KB, doc)